TOKYO, November 23 ------ A panel of the Japanese health ministry granted fast-track approval to Shionogi & Co.'s oral COVID-19 drug.
The medicine for coronavirus patients with mild symptoms will be the country's first domestically produced oral drug against the virus. The decision comes as Japan has recently seen a rebound in the number of daily coronavirus cases.
The government has eased restrictions on people's activity including removing its cap on daily foreign arrivals, while also starting a subsidy program for residents to boost domestic tourism.
Source: news.abs-cbn.com